Does IBANDRONATE Cause Malignant neoplasm progression? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Malignant neoplasm progression have been filed in association with IBANDRONATE (Ibandronate Sodium). This represents 0.3% of all adverse event reports for IBANDRONATE.
34
Reports of Malignant neoplasm progression with IBANDRONATE
0.3%
of all IBANDRONATE reports
4
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From IBANDRONATE?
Of the 34 reports, 4 (11.8%) resulted in death, and 1 (2.9%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IBANDRONATE. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does IBANDRONATE Cause?
Femur fracture (990)
Arthralgia (975)
Pain (779)
Pain in extremity (726)
Back pain (688)
Myalgia (623)
Diarrhoea (551)
Low turnover osteopathy (521)
Nausea (480)
Anxiety (456)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which IBANDRONATE Alternatives Have Lower Malignant neoplasm progression Risk?
IBANDRONATE vs IBANDRONIC ACID
IBANDRONATE vs IBERDOMIDE
IBANDRONATE vs IBREXAFUNGERP
IBANDRONATE vs IBRITUMOMAB TIUXETAN
IBANDRONATE vs IBRUTINIB